Group One Trading, L.P. Kempharm, Inc Transaction History

Group One Trading, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	N/A	11,308 Added 66.66%	28,272 $139,000
Q1 2024 May 10, 2024	SELL	N/A	-22,664 Reduced 57.19%	16,964 $83,000
Q4 2023 Feb 14, 2024	BUY	N/A	3,729 Added 10.39%	39,628 $195,000
Q3 2023 Nov 09, 2023	SELL	N/A	-11,196 Reduced 23.77%	35,899 $177,000
Q2 2023 Aug 09, 2023	SELL	$4.94 - $6.29 $13,999 - $17,825	-2,834 Reduced 5.68%	47,095 $232,000
Q1 2023 May 12, 2023	SELL	$4.13 - $6.27 $107,660 - $163,446	-26,068 Reduced 34.3%	49,929 $274,000
Q4 2022 Feb 09, 2023	BUY	$4.12 - $5.62 $313,107 - $427,103	75,997 New	75,997 $348,000
Q2 2021 Aug 10, 2021	SELL	$8.52 - $15.47 $112,148 - $203,631	-13,163 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$5.6 - $13.47 $73,712 - $177,305	13,163 New	13,163 $121,000

117

26.1M

591K

242K

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.